metricas

Medicina Clínica

Sugerencias
Medicina Clínica Pruebas diagnósticas COVID-19: importancia del contexto clínico
Información de la revista
Vol. 157. Núm. 4.
Páginas 159-218 (Agosto 2021)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
14946
Vol. 157. Núm. 4.
Páginas 159-218 (Agosto 2021)
Revisión

Pruebas diagnósticas COVID-19: importancia del contexto clínico

COVID-19 diagnostic tests: importance of the clinical context
Visitas
14946
Marc Vila Muntadasa,
Autor para correspondencia
marcvilamuntadas@gmail.com

Autor para correspondencia.
, Inés Agustí Sunyerb, Alvar Agustí Garcia-Navarrob,c,d
a Equip d’Atenció Primària Vic (EAPVIC), Vic, Barcelona, España
b Hospital Clínic de Barcelona, Barcelona, España
c Universidad de Barcelona (UB), Barcelona, España
d CIBER Enfermedades Respiratorias, Madrid, España
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Resumen

La actual pandemia de SARS-CoV-2 plantea numerosos retos sanitarios, entre los que destaca el uso adecuado e interpretación correcta de las pruebas diagnósticas disponibles en diferentes contextos clínicos. Como cualquier prueba diagnóstica, las de SARS-CoV-2 tienen limitaciones metodológicas de sensibilidad (S) y especificidad (E) que determinan su valor predictivo positivo (VPP) y negativo (VPN). Además, su rendimiento diagnóstico depende del contexto clínico en el que se evalúen, es decir de la probabilidad pretest. Este artículo revisa los principales aspectos metodológicos que influyen sobre la S, E, VPP y VPN de las pruebas diagnósticas de SARS-CoV-2 más habituales y discute su interpretación diagnóstica en diferentes escenarios clínicos.

Palabras clave:
Coronavirus
Diagnóstico
Transmisión
Cuadro clínico
Prevención
SARS-CoV-2
Abstract

The current SARS-CoV-2 pandemic poses numerous health challenges, including the adequate use and proper interpretation of the different available tests in different clinical settings. As any diagnostic test, those of SARS-CoV-2 have methodological limitations of sensitivity (S) and specificity (E), which eventually determine their positive (PPV) and negative (NPV) predictive value. Furthermore, their diagnostic performance depends on the clinical context in which these tests are used, that is, on the pretest probability. This article: (1) reviews the main methodological aspects that influence the S, E, PPV and NPV of the most common SARS-CoV-2 diagnostic tests; and, (2) discusses its diagnostic interpretation in different clinical settings.

Keywords:
Coronavirus
Diagnosis
Transmission
Clinical picture
Prevention
SARS-CoV-2

Artículo

Opciones para acceder a los textos completos de la publicación Medicina Clínica
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
G.M. Bwire, M.V. Majigo, B.J. Njiro, A. Mawazo.
Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis.
J Med Virol., 93 (2021), pp. 719-725
[2]
M.M. Wahidi, C. Lamb, S. Murgu, A. Musani, S. Shojaee, A. Sachdeva, et al.
American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection.
J Bronchol Interv Pulmonol., 27 (2020), pp. e52-e54
[3]
V.M. Corman, O. Landt, M. Kaiser, R. Molenkamp, A. Meijer, D.K. Chu, et al.
Detection of 2019 -nCoV by RT-PCR.
Euro Surveill., 25 (2020), pp. 1-8
[4]
L.L. Wyllie, J. Fournier, A. Casanovas-Massana, M. Campbell, M. Tokuyama, P. Vijayakumar, et al.
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
N Engl J Med., 383 (2020), pp. 2008-2009
[5]
C. Morales Angulo, R. González Zubizarreta, G. Martín Toca, A. Ramírez Bonilla, M. Gonzalo Margüello, A. Rodriguez Fernández.
Nasopharyngeal swab for the diagnosis of COVID-19.
Rev ORL., (2020), pp. 5
[6]
Y. Yang, M. Yang, C. Shen, F. Wang, J. Yuan, J. Li, et al.
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections.
BMJ., (2020),
[7]
I. Kokkinakis, K. Selby, B. Favrat, B. Genton, J. Cornuz.
Covid-19 diagnosis: clinical recommendations and performance of nasopharyngeal swab-PCR.
Rev Med Suisse., 16 (2020), pp. 699-701
[8]
C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
[9]
Y. Pan, D. Zhang, P. Yang, L.L.M. Poon, Q. Wang.
Viral load of SARS-CoV-2 in clinical samples.
Lancet Infect Dis., 20 (2020), pp. 411-412
[10]
M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, et al.
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell., 181 (2020), pp. 271-280
[11]
J. Ceron, E. Lamy, S. Martinez-Subiela, P. Lopez-Jornet, F. Capela-Silva, P. Eckersall, et al.
Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.
J Clin Med., 9 (2020), pp. 1491
[12]
S. Iwasaki, S. Fujisawa, S. Nakakubo, K. Kamada, Y. Yamashita, T. Fukumoto, et al.
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
J Infect., 81 (2020), pp. 145-147
[13]
F. Parada-Fernández, D. Fonseca-Escobar, M. Carvajal-Guzmán, C. Sepúlveda-Verdugo.
Comparación de la Muestra Salival y de Nasofaringe en la Detección de SARS-CoV-2 mediante RT-PCR.
Int J Odontostomatol., 14 (2020), pp. 540-543
[14]
M. Zuo, Y. Huang, W. Ma, Z. Xue, J. Zhang, Y. Gong, et al.
Expert Recommendations for Tracheal Intubation in Critically III Patients with Noval Coronavirus Disease 2019.
Chinese Med Sci J., 35 (2020), pp. 105-109
[15]
F. Patrucco, C. Albera, M. Bellocchia, V. Foci, F. Gavelli, L.M. Castello, et al.
SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience.
[16]
V. Kipkorir, I. Cheruiyot, B. Ngure, M. Misiani, J. Munguti.
Prolonged SARS-CoV-2 RNA detection in anal/rectal swabs and stool specimens in COVID-19 patients after negative conversion in nasopharyngeal RT-PCR test.
J Med Virol., 92 (2020), pp. 2328-2331
[17]
H. Wang, X. Li, T. Li, S. Zhang, L. Wang, X. Wu, et al.
The genetic sequence, origin, and diagnosis of SARS-CoV-2.
Eur J Clin Microbiol Infect Dis., 39 (2020), pp. 1629-1635
[18]
K.M. Koczula, A. Gallotta.
Lateral flow assays.
Essays Biochem., 60 (2016), pp. 111-120
[19]
G.C. Mak, P.K. Cheng, S.S. Lau, K.K. Wong, C.S. Lau, E.T. Lam, et al.
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus.
J Clin Virol., 129 (2020), pp. 104500
[20]
Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud.
Estrategia de detección precoz, vigilancia y control de COVID-19.
Minist Sanid Gob España Inst Salud Carlos III, (2020), pp. 1-16
[21]
W. Zhang, R.H. Du, B. Li, X.S. Zheng, X. Yang, B. Lou Hu, et al.
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.
Emerg Microbes Infect., 9 (2020), pp. 386-389
[22]
X. Liu, J. Wang, X. Xu, G. Liao, Y. Chen, C.H. Hu.
Patterns of IgG and IgM antibody response in COVID-19 patients.
Emerg Microbes Infect., 9 (2020), pp. 1269-1274
[23]
D.T.H. De Moura, T.R. McCarty, I.B. Ribeiro, M.P. Funari, P.V.A.G. de Oliveira, A.A. de Miranda Neto, et al.
Diagnostic characteristics of serological-based COVID-19 testing: A systematic review and meta-analysis.
Clinics., 75 (2020), pp. 1-11
[24]
F. Xiang, X. Wang, X. He, Z. Peng, B. Yang, J. Zhang, et al.
Antibody Detection and Dynamic Characteristics in Patients with Coronavirus Disease 2019.
Clin Infect Dis., 71 (2020), pp. 1930-1934
[25]
M.B. Mazanec, C.S. Kaetzel, M.E. Lamm, D. Fletcher, J.G. Nedrud.
Intracellular neutralization of virus by immunoglobulin A antibodies.
Proc Natl Acad Sci U S A., 89 (1992), pp. 6901-6905
[26]
R.H. See, A.N. Zakhartchouk, M. Petric, D.J. Lawrence, C.P.Y. Mok, R.J. Hogan, et al.
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
J Gen Virol., 87 (2006), pp. 641-650
[27]
D. Sterlin, A. Mathian, M. Miyara, A. Mohr, F. Anna, L. Claer, et al.
IgA dominates the early neutralizing antibody response to SARS-CoV-2.
Sci Transl Med., 2223 (2020), pp. 1-14
[28]
A. Grifoni, D. Weiskopf, S.I. Ramirez, J. Mateus, J.M. Dan, C.R. Moderbacher, et al.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Cell., 181 (2020), pp. 1489-1501
[29]
S.M. Kissler, C. Tedijanto, E. Goldstein, Y.H. Grad, M. Lipsitch.
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.
Science., 368 (2020), pp. 860-868
[30]
J.P. Salameh, M.M.G. Leeflang, L. Hooft, N. Islam, T.A. McGrath, C.B. van der Pol, et al.
Thoracic imaging tests for the diagnosis of COVID-19.
Cochrane Database Syst Rev., (2020),
[31]
Y. Kobayashi, T. Mitsudomi.
Management of ground-glass opacities: Should all pulmonary lesions with ground-glass opacity be surgically resected?.
Transl Lung Cancer Res., 2 (2013), pp. 354-363
[32]
X. Ding, J. Xu, J. Zhou, Q. Long.
Chest CT findings of COVID-19 pneumonia by duration of symptoms.
Eur J Radiol., 127 (2020), pp. 109009
[33]
S. Salehi, A. Abedi, S. Balakrishnan, A. Gholamrezanezhad.
Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients.
Am J Roentgenol., 215 (2020), pp. 87-93
[34]
M. Chung, A. Bernheim, X. Mei, N. Zhang, M. Huang, X. Zeng, et al.
CT imaging features of 2019 novel coronavirus (2019-NCoV).
Radiology., 295 (2020), pp. 202-207
[35]
J. Wu, X. Wu, W. Zeng, D. Guo, Z. Fang, L. Chen, et al.
Chest CT Findings in Patients with Coronavirus Disease 2019 and Its Relationship with Clinical Features.
Invest Radiol., 55 (2020), pp. 257-261
[36]
F. Pan, T. Ye, P. Sun, S. Gui, B. Liang, et al.
Time Course of Lung Changes at Chest CT during Recovery.
Radiology., 295 (2020), pp. 715-721
[37]
T. Ai, Z. Yang, H. Hou, C. Zhan, C. Chen, W. Lv, et al.
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.
Radiology., 296 (2020), pp. E32-E40
[38]
C.A. Raptis, M.M. Hammer, R.G. Short, P.D. Filev, M.D. Hope, J. Jeudy, et al.
Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date.
AJR Am J Roentgenol, 215 (2020), pp. 839-842
[39]
A. Jacobi, M. Chung, A. Bernheim, C. Eber.
Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review.
Clin Imaging., 64 (2020), pp. 35-42
[40]
A.L. Wangüemert Pérez.
La ecografía pulmonar antes y después del SARS-CoV-2.
Arch Bronconeumol., 57 (2020), pp. 9-10
[41]
Q.Y. Peng, X.T. Wang, L.N. Zhang.
Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic.
Intensive Care Med., 46 (2020), pp. 849-850
[42]
N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, et al.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan China: a descriptive study.
[43]
Q. Ruan, K. Yang, W. Wang, L. Jiang, J. Song.
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Intensive Care Med., 46 (2020), pp. 846-848
[44]
E. Driggin, M.V. Madhavan, B. Bikdeli, T. Chuich, P.D. Harm, D.A. Zidar, et al.
Cardiovascular Considerations for Patients Health CareWorkers, and Health Systems During the COVID-19 Pandemic and information.
J Am Coll Cardiol., (2020), pp. 75
[45]
A. Bardají, A. Carrasquer, R. Sánchez-Giménez, N. Lal-Trehan, V. del-Moral-Ronda, Peiró ÓM, et al.
Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital.
Rev Esp Cardiol., (2020),
[46]
F.E. Jara González, G. de Fátima Jimenez Alulima, E.L. Sananay Auquilla, J.C. Murillo Sanclemente, P.A. Molina Vasquez, J.L. Vélez Páez.
Hipercoagulabilidad, trombosis intravascular y trombocitosis asociada al COVID-19. Reporte de un caso.
Bionatura., 5 (2020), pp. 1138-1141
[47]
J.F. Figueroa Triana, D.A. Salas Márquez, J.S. Cabrera Silva, C.C. Alvarado Castro, A.F. Buitrago Sandoval.
COVID-19 and cardiovascular disease.
Rev Colomb Cardiol., 27 (2020), pp. 166-174
[48]
M.K. Parvez.
COVID-19 and coronaviral hepatitis: Evidence of collateral damage.
Future Virol., (2020), pp. 15
[49]
A. Blake, D. Collins, E. O’Connor, C. Bergin, A.M. McLaughlin, I. Martin-Loeches.
Clinical and biochemical characteristics of patients admitted to ICU with SARS-CoV-2.
Med Intensiva (English Ed)., 44 (2020), pp. 589-590
[50]
C.B. Good, I. Hernandez, K. Smith.
Interpreting COVID-19 Test Results: a Bayesian Approach.
J Gen Intern Med., 35 (2020), pp. 2490-2491
[51]
B. Udugama, P. Kadhiresan, H.N. Kozlowski, A. Malekjahani, M. Osborne, V.Y.C. Li, et al.
Diagnosing COVID-19: The Disease and Tools for Detection.
ACS Nano., 14 (2020), pp. 3822-3835
[52]
M. Cuenca Saez, S. Gomez-Biezna.
Presencia de anticuerpos antifosfolípidos IgA en pacientes con lesiones pernióticas asociadas a COVID-19.
Actas Dermosifiliogr., (2020), pp. 19-21
[53]
F. Hernansanz Iglesias.
Epidemiología básica de COVID-19.
AMF., 16 (2020),
[54]
M. Lisboa Bastos, G. Tavaziva, S.K. Abidi, J.R. Campbell, L.P. Haraoui, J.C. Johnston, et al.
Diagnostic accuracy of serological tests for covid-19: Systematic review and meta-analysis.
BMJ., (2020), pp. 370
[55]
V. Soriano, P. Ganado-Pinilla, M. Sánchez-Santos, P. Barreiro.
Unveiling Long COVID-19 Disease.
Aids Rev., 22 (2020), pp. 227-228
[56]
J. Bullard, K. Dust, D. Funk, J.E. Strong, D. Alexander, L. Garnett, et al.
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.
Clin Infect Dis., (2020), pp. 1-4
[57]
J.M. Mina, M. Parker, R.D.B. Larremore.
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment.
N Engl J Med., 383 (2020), pp. e120-e123
[58]
M.R. Tom, M.J. Mina.
To Interpret the SARS-CoV-2 Test Consider the Cycle Threshold Value.
Clin Infect Dis., 71 (2020), pp. 2252-2254
[59]
A. Singanayagam, M. Patel, A. Charlett, J.L. Bernal, V. Saliba, J. Ellis, et al.
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England January to May 2020.
Euro Surveill., 25 (2020), pp. 1-5
[60]
J. Malagón-Rojas, C. Gómez-Rendón, E.L. Parra, J. Almentero, R. Palma, R. López, et al.
SARS-CoV-2 y RT-PCR en pacientes asintomáticos: resultados de una cohorte de trabajadores del Aeropuerto Internacional El Dorado de Bogotá.
Biomedica., 40 (2020), pp. 166-172
asdasdasd
Opciones de artículo
Herramientas